Immunotherapy has emerged as a cornerstone in NSCLC treatment, yet the tumor microenvironment varies significantly between LUAD and LUSC, impacting responses to immune checkpoint inhibitors. While ...
Comparison of targetable driver gene mutation frequencies in lung adenocarcinoma and lung squamous cell carcinoma. Lung cancer remains one of the leading causes of cancer-related mortality, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback